Abano Healthcare Group Limited provided earnings guidance for the first half ended November 30, 2015. For the period, the company expects revenue to be $105 million to $109 million and gross revenues are expected to be $150 million to $154 million. EBITDA is expected to be $11.9 million to $13.1 million with underlying EBITDA of $12.5 million to $13.7 million.

Net profit after tax is expected to be at between $3.0 million to $3.6 million, with underlying NPAT of between $3.5 million to $4.1 million.